← Browse by Condition
Medical Condition

thrombosis

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3, Phase 3

ClinicalMetric tracks all active clinical trials for thrombosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — thrombosis Clinical Trials

How many clinical trials are currently recruiting for thrombosis?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for thrombosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for thrombosis?
thrombosis research spans Phase 2 (1 trial), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a thrombosis clinical trial?
Eligibility criteria for thrombosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
2
Top Sponsors
American Thrombosis and Hemostasis Network 1 trial
Ottawa Hospital Research Institute 1 trial
Queen Mary University of London 1 trial
Nedim Tojaga 1 trial
University of Edinburgh 1 trial

Recruiting Clinical Trials

NCT04398628
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost...
View Trial →
NCT06965998 Phase 2, Phase 3
Recruiting
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
Enrollment
50 pts
Location
Canada
Sponsor
Ottawa Hospital Research Insti...
View Trial →
NCT06370273 Phase 3
Recruiting
Thromboprophylaxis in Lower Limb Immobilisation
Enrollment
10,044 pts
Location
United Kingdom
Sponsor
Queen Mary University of Londo...
View Trial →
NCT06949319
Recruiting
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
Enrollment
150 pts
Location
Denmark
Sponsor
Nedim Tojaga
View Trial →
NCT06113510
Recruiting
Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction
Enrollment
80 pts
Location
United Kingdom
Sponsor
University of Edinburgh
View Trial →
NCT07137429
Recruiting
Platelet Volunteers, Longitudinal and Multi-omic Study
Enrollment
400 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo...
View Trial →
NCT06727669
Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Enrollment
3,000 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →

Related Conditions

bleeding disorder (2) thrombophilia (2) hematologic disorder (1) connective tissue disorder (1) hemophilia (1) von willebrand diseases (1) rare bleeding disorder (1) platelet disorder (1) factor ix deficiency (1) factor viii deficiency (1) thalassemia (1) sickle cell disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology